Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Trisomy 21
100%
Lung Disease
100%
Cellular Senescence
100%
Down Syndrome
62%
Senolytics
31%
Senomorphics
31%
Senescent Cells
31%
Mesenchymal Cells
20%
IFN-I
20%
Tracheobronchial Malacia
18%
Tracheobronchial Airway
18%
Perinatal Factors
18%
Causes of Hospitalization
18%
Children with Down Syndrome
18%
Wheezing
18%
Neonate
18%
Clinically Significant
18%
Vulnerable Populations
18%
Lung
18%
IFN-I Signaling
10%
Upper Airway muscles
10%
Progeria
10%
Dasatinib
10%
Health Problems
10%
Novel Therapies
10%
Profibrotic
10%
Senescence-associated Secretory Phenotype
10%
Explant Model
10%
G1 Cell Cycle Arrest
10%
Live Birth
10%
Immune Clearance
10%
DNA Damage
10%
Oxidative Stress
10%
Flavonoids
10%
Pediatric Samples
10%
Quercetin
10%
Fisetin
10%
Human Lung Tissue
10%
Early Aging
10%
Paracrine Effect
10%
Ex Vivo Explant
10%
Cell number
10%
Primary Lung
10%
Early Postnatal Period
10%
Nave
10%
Muscle Tone
10%
Strawberry
10%
Airway Obstruction
10%
Pulmonary Complications
10%
Adults with Down Syndrome
8%
Brain Cells
8%
Unmet Medical Need
8%
Upper Airway Disease
8%
Early Infancy
8%
Medicine and Dentistry
Trisomy 21
100%
Silo-Filler's Disease
100%
Cellular Senescence
100%
Down Syndrome
72%
Lung
27%
Neonate
17%
Wheeze
17%
Vulnerable Population
17%
Tracheobronchomalacia
17%
Airway Obstruction
10%
Upper Airway Muscle
9%
Pediatrics
9%
Ex Vivo
9%
Progeria
9%
G1/S Transition
9%
DNA Damage
9%
Muscle Tone
9%
Oxidative Stress
9%
Quercetin
9%
Fisetin
9%
Flavonoid
9%
Dasatinib
9%
Brain Cell
8%
Infancy
8%
Respiratory Disease
8%
Biochemistry, Genetics and Molecular Biology
Trisomy 21
75%
Down Syndrome
64%
Progeria
9%
Flavonoid
9%
Pediatrics
9%
Cell Count
9%
Oxidative Stress
9%
Vulnerable Population
9%
G1/S Transition
9%
Dasatinib
9%
Quercetin
9%
Muscle Tone
9%
DNA Damage
9%
Explant
9%